MedTrace Logo

Neurodevelopmental Disorders in Youth With Criminal Behaviors

NCT05875363 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2023-05-25

No results posted yet for this study

Summary

1. Describe the prevalence of neurodevelopmental disorders among youth with criminal behaviors
2. Explore the relationship between specific neurodevelopmental disorders and the rates and types of crime
3. Examine the roles of psychiatric comorbidities and sociodemographic factors in juvenile criminality

Conditions

  • Attention Deficit Disorder With Hyperactivity
  • Autistic Spectrum Disorder
  • Conduct Disorders in Adolescence

Interventions

OTHER

collect data

The Juvenile Affairs Division provided the records without person-identifiable data (i.e., name, ID) to the researchers. The researchers coded the above data (i.e., the offenders' sociodemographic data, medical history, and criminal history). Demographic characteristics were collected, which are the offenders' age, gender, occupation, education level, and residence (district). We recorded the offenders' household members (without the name or age), main caregivers (e.g., father, or mother), and the parents' socioeconomic and marital status. We also tracked whether the offenders live with family members with mental illness, whether they are from at-risk families, and whether had been victims of domestic violence. The medical history and deviant (or criminal) behaviors will be collected in the attached measure.

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Eligibility

Min Age
10 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-01
Primary Completion
2021-07-31
Completion
2021-10-25

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05875363 on ClinicalTrials.gov